Efficacy of cytokine-induced killer cell-based immunotherapy for hepatocellular carcinoma.
Changchang Jia(Third Affiliated Hospital of Sun Yat-sen University), Qi Zhang(Jiamusi University), Xiangyuan Wu(Zhejiang University), Xiurong Cai(Sun Yat-sen University), Liyun Zhao(Hebei Medical University), Shu‐Juan Xie(Sun Yat-sen University), Zhicheng Yao(Tianjin University of Traditional Chinese Medicine), Chang Liu(Paul Scherrer Institute), Tiantian Wang(Sun Yat-sen University), Wenjie Chen(Commercial Aircraft Corporation of China (China)), Yunhao Chen(Shanxi Agricultural University), Qiuli Liu(Army Medical University), Dongbo Qiu(Sun Yat-sen University), Li Yang(Anyang Eye Hospital), Xiaofang Zheng(Hunan University)
PubMed
January 1, 2019
Cited by 17
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k